PMC5037123_01
PMC5037123_02
Gastrografin study following sleeve gastrectomy showing absence of leakage.
gr1.jpg
PMC5037123_02_gr1.jpg
fig0005
The patient had an uneventful recovery, with no evidence of leak from the gastric staple line (Fig. 1) and she was discharged 2 weeks after the combined procedure.
BMI Trend.
gr2.jpg
PMC5037123_02_gr2.jpg
fig0010
The patient is currently alive, 5 months after the combined procedure, with normal allograft function, non detectable HCV RNA level, showing significant weight loss (BMI = 29 kg/m2, BMI trend is shown in Fig. 2), no longer requiring insulin or oral hypo-glycemic treatment; she is actually only on immunosuppression drugs (pre and post-LT patient and donor details are showed in Table 1).